Description |
1 online resource (188 pages) |
Physical Medium |
polychrome |
Description |
text file |
Summary |
Over the past decade, the transient gene expression (TGE) technology platform has been actively pursued to produce a wide range of therapeutic proteins, monoclonal antibodies, and vaccines for mainly preclinical assessment, due to its short development times and low overall cost. This book updates the latest advances in the field, with focusing on systematic description of the technology from cell lines, cell culture conditions, vector construction, expression strategy, current protocols, optimisation of the procedure, and potential for clinical application. As a conclusion, the author foresee. |
Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
Subject |
Recombinant proteins -- Therapeutic use.
|
|
Recombinant proteins. |
|
Gene expression.
|
|
Gene expression. |
Genre/Form |
Electronic books.
|
ISBN |
9781847359773 (electronic book) |
|
1847359779 (electronic book) |
|
1847359760 |
|
9781847359766 |
|